Podcast Episodes

Back to Search
Episode 59: Ipatercertib in biomarker positive castrate resistant prostate cancer
Episode 59: Ipatercertib in biomarker positive castrate resistant prostate cancer

Chris Sweeney (last author) discusses the ATK inhibitor Ipatercertib in pTEN altered CRPC. A positive R3 trial in the ESMO plenary session. 

6 years, 1 month ago

Short Long
View Episode
Episode 58: Brilliant ESMO discussant Richard Cathomas talks to Brian and Tom about the meaning of DANUBE and KN362
Episode 58: Brilliant ESMO discussant Richard Cathomas talks to Brian and Tom about the meaning of DANUBE and KN362

Season 1 Episode 58

The group go into the detail of chemo immune combinations and what to do next. 

6 years, 1 month ago

Short Long
View Episode
Episode 57: Toni Choueiri - cabo & nivo vs sunitinib in metastatic clear cell renal cancer
Episode 57: Toni Choueiri - cabo & nivo vs sunitinib in metastatic clear cell renal cancer

Season 1 Episode 57

The group attempts to put the data into context with the other available combinations.

6 years, 1 month ago

Short Long
View Episode
Episode 56: Matt Galsky and Tom Powles discuss ESMO 2020 immune therapy data in bladder cancer
Episode 56: Matt Galsky and Tom Powles discuss ESMO 2020 immune therapy data in bladder cancer

Season 1 Episode 56

The group try to get to the bottom of whether these data has made any difference in treatment and future plans. 

6 years, 1 month ago

Short Long
View Episode
Episode 55: The Uromigos Paper of the Month - Cabozantinib in Bladder Cancer by Dr. Andrea Apolo
Episode 55: The Uromigos Paper of the Month - Cabozantinib in Bladder Cancer by Dr. Andrea Apolo

Season 1 Episode 55

Andrea talks about her phase 2 trial which shows activity for Cabozantinib in urothelial cancer. 

6 years, 1 month ago

Short Long
View Episode
Episode 54: Biomarkers in prostate cancer with Chris Sweeney
Episode 54: Biomarkers in prostate cancer with Chris Sweeney

Season 1 Episode 54

Some thought it would never come - the final podcast of the World Tour from Boston.

6 years, 3 months ago

Short Long
View Episode
Episode 53: Still in Boston - biomarkers in bladder cancer
Episode 53: Still in Boston - biomarkers in bladder cancer

Season 1 Episode 53

Tom, Brian and Chris Sweeney discuss the challenges of development of biomarkers for immune therapy in bladder cancer. 

6 years, 3 months ago

Short Long
View Episode
Episode 52: The Final Stop - Boston: David McDermott discusses biomarkers in renal cancer in the era of immune therapy
Episode 52: The Final Stop - Boston: David McDermott discusses biomarkers in renal cancer in the era of immune therapy

Season 1 Episode 52

Tom, David and Brian discuss biomarkers in renal cancer in the era of immune therapy.

6 years, 3 months ago

Short Long
View Episode
Episode 51: The Uromigos World Tour is in Norway with Jan Oldenburg - discussing key topics in testis cancer
Episode 51: The Uromigos World Tour is in Norway with Jan Oldenburg - discussing key topics in testis cancer

Season 1 Episode 51

Jan Oldenburg from Norway discusses treatment choices for stage 1 testis cancer, the dilemma of high dose therapy for relapse and long term toxicity …

6 years, 3 months ago

Short Long
View Episode
Episode 50: The Uromigos World Tour in London with renal cancer surgery
Episode 50: The Uromigos World Tour in London with renal cancer surgery

Season 1 Episode 50

Axel Bex talks about small renal masses, robotic vs partial nephrectomy and surgery in metastatic disease. 

6 years, 3 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us